Continuous Processing for Viral Vectors: Manufacturers are taking the first steps toward process intensification.
| Publicado en: | BioPharm International Vol. 35; no. 8; pp. 31 - 35 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Aug2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158451722&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 158451722 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Aug2022 vid: 35 iid: 8 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 158451722 158451722 158451722 158451722 ppf: 31 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Continuous Processing for Viral Vectors: Manufacturers are taking the first steps toward process intensification. aug: au: CHALLENER, CYNTHIA A. affil: PhD, is contributing editor to BioPharm International sug: subj: Disease Vectors Cell Culture Techniques Methods Manufacturing Industry Antibodies, Monoclonal Recombinant Proteins Technology, Pharmaceutical Genes pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|